Amoxapine |
Asendin |
Article: Amoxapine
![]() | |
| Amoxapine | |
| Systematic (IUPAC) name | |
| ? | |
| Identifiers | |
| CAS number | 14028-44-5 |
| ATC code | N06AA17 |
| PubChem | 2170 |
| DrugBank | APRD00142 |
| Chemical data | |
| Formula | C17H16ClN3O |
| Mol. weight | 313.781 |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Routes | ? |
Amoxapine (brand-names Asendin®, Asendis®, Defanyl®, Demolox®, Moxadil®) is a tricyclic antidepressant of the dibenzoxazepine class. It is used in the treatment of depression, panic disorders and bipolar disorder.
Amoxapine is a strong reuptake inhibitor of norepinephrine and weak reuptake reuptake inhibitor of serotonin. One of its major metabolites, 7-hydroxyamoxapine, has a dopamine receptor blocking effect.

Not Signed In - 


